Atrial Function in Patients with Breast Cancer After Treatment with Anthracyclines
Abstract Background: Atrial electromechanical delay (EMD) is used to predict atrial fibrillation, measured by echocardiography. Objectives: The aim of this study was to assess atrial EMD and mechanical function after anthracycline-containing chemotherapy. Methods: Fifty-three patients with breast...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Cardiologia (SBC)
|
Series: | Arquivos Brasileiros de Cardiologia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016005025103&lng=en&tlng=en |
id |
doaj-0e8bfde6c1764d25b319bfb4fbd407d6 |
---|---|
record_format |
Article |
spelling |
doaj-0e8bfde6c1764d25b319bfb4fbd407d62020-11-24T21:03:20ZengSociedade Brasileira de Cardiologia (SBC)Arquivos Brasileiros de Cardiologia1678-4170010.5935/abc.20160146S0066-782X2016005025103Atrial Function in Patients with Breast Cancer After Treatment with AnthracyclinesYalin Tolga YaylaliAhmet SaricopurMustafa YurtdasHande SenolGamze Gokoz-DoguAbstract Background: Atrial electromechanical delay (EMD) is used to predict atrial fibrillation, measured by echocardiography. Objectives: The aim of this study was to assess atrial EMD and mechanical function after anthracycline-containing chemotherapy. Methods: Fifty-three patients with breast cancer (48 ± 8 years old) who received 240 mg/m2of Adriamycin, 2400 mg/m2 of cyclophosphamide, and 960 mg/m2 of paclitaxel were included in this retrospective study, as were 42 healthy subjects (47 ± 9 years old). Echocardiographic measurements were performed 11 ± 7 months (median 9 months) after treatment with anthracyclines. Results: Left intra-atrial EMD (11.4 ± 6.0 vs. 8.1 ± 4.9, p=0.008) and inter-atrial EMD (19.7 ± 7.4 vs. 14.7 ± 6.5, p=0.001) were prolonged; LA passive emptying volume and fraction were decreased (p=0.0001 and p=0.0001); LA active emptying volume and fraction were increased (p=0.0001 and p=0.0001); Mitral A velocity (0.8 ± 0.2 vs. 0.6 ± 0.2, p=0.0001) and mitral E-wave deceleration time (201.2 ± 35.6 vs. 163.7 ± 21.8, p=0.0001) were increased; Mitral E/A ratio (1.0 ± 0.3 vs. 1.3 ± 0.3, p=0.0001) and mitral Em (0.09 ± 0.03 vs. 0.11 ± 0.03, p=0.001) were decreased; Mitral Am (0.11 ± 0.02 vs. 0.09 ± 0.02, p=0.0001) and mitral E/Em ratio (8.8 ± 3.2 vs. 7.6 ± 2.6, p=0.017) were increased in the patients. Conclusions: In patients with breast cancer after anthracycline therapy: Left intra-atrial, inter-atrial electromechanical intervals were prolonged. Diastolic function was impaired. Impaired left ventricular relaxation and left atrial electrical conduction could be contributing to the development of atrial arrhythmias.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016005025103&lng=en&tlng=enAtrial FunctionArrhythmias, CardiacUnilateral Breast NeoplasmsAntrhacyclinesDrug TherapyCardiotoxicity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yalin Tolga Yaylali Ahmet Saricopur Mustafa Yurtdas Hande Senol Gamze Gokoz-Dogu |
spellingShingle |
Yalin Tolga Yaylali Ahmet Saricopur Mustafa Yurtdas Hande Senol Gamze Gokoz-Dogu Atrial Function in Patients with Breast Cancer After Treatment with Anthracyclines Arquivos Brasileiros de Cardiologia Atrial Function Arrhythmias, Cardiac Unilateral Breast Neoplasms Antrhacyclines Drug Therapy Cardiotoxicity |
author_facet |
Yalin Tolga Yaylali Ahmet Saricopur Mustafa Yurtdas Hande Senol Gamze Gokoz-Dogu |
author_sort |
Yalin Tolga Yaylali |
title |
Atrial Function in Patients with Breast Cancer After Treatment with Anthracyclines |
title_short |
Atrial Function in Patients with Breast Cancer After Treatment with Anthracyclines |
title_full |
Atrial Function in Patients with Breast Cancer After Treatment with Anthracyclines |
title_fullStr |
Atrial Function in Patients with Breast Cancer After Treatment with Anthracyclines |
title_full_unstemmed |
Atrial Function in Patients with Breast Cancer After Treatment with Anthracyclines |
title_sort |
atrial function in patients with breast cancer after treatment with anthracyclines |
publisher |
Sociedade Brasileira de Cardiologia (SBC) |
series |
Arquivos Brasileiros de Cardiologia |
issn |
1678-4170 |
description |
Abstract Background: Atrial electromechanical delay (EMD) is used to predict atrial fibrillation, measured by echocardiography. Objectives: The aim of this study was to assess atrial EMD and mechanical function after anthracycline-containing chemotherapy. Methods: Fifty-three patients with breast cancer (48 ± 8 years old) who received 240 mg/m2of Adriamycin, 2400 mg/m2 of cyclophosphamide, and 960 mg/m2 of paclitaxel were included in this retrospective study, as were 42 healthy subjects (47 ± 9 years old). Echocardiographic measurements were performed 11 ± 7 months (median 9 months) after treatment with anthracyclines. Results: Left intra-atrial EMD (11.4 ± 6.0 vs. 8.1 ± 4.9, p=0.008) and inter-atrial EMD (19.7 ± 7.4 vs. 14.7 ± 6.5, p=0.001) were prolonged; LA passive emptying volume and fraction were decreased (p=0.0001 and p=0.0001); LA active emptying volume and fraction were increased (p=0.0001 and p=0.0001); Mitral A velocity (0.8 ± 0.2 vs. 0.6 ± 0.2, p=0.0001) and mitral E-wave deceleration time (201.2 ± 35.6 vs. 163.7 ± 21.8, p=0.0001) were increased; Mitral E/A ratio (1.0 ± 0.3 vs. 1.3 ± 0.3, p=0.0001) and mitral Em (0.09 ± 0.03 vs. 0.11 ± 0.03, p=0.001) were decreased; Mitral Am (0.11 ± 0.02 vs. 0.09 ± 0.02, p=0.0001) and mitral E/Em ratio (8.8 ± 3.2 vs. 7.6 ± 2.6, p=0.017) were increased in the patients. Conclusions: In patients with breast cancer after anthracycline therapy: Left intra-atrial, inter-atrial electromechanical intervals were prolonged. Diastolic function was impaired. Impaired left ventricular relaxation and left atrial electrical conduction could be contributing to the development of atrial arrhythmias. |
topic |
Atrial Function Arrhythmias, Cardiac Unilateral Breast Neoplasms Antrhacyclines Drug Therapy Cardiotoxicity |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016005025103&lng=en&tlng=en |
work_keys_str_mv |
AT yalintolgayaylali atrialfunctioninpatientswithbreastcanceraftertreatmentwithanthracyclines AT ahmetsaricopur atrialfunctioninpatientswithbreastcanceraftertreatmentwithanthracyclines AT mustafayurtdas atrialfunctioninpatientswithbreastcanceraftertreatmentwithanthracyclines AT handesenol atrialfunctioninpatientswithbreastcanceraftertreatmentwithanthracyclines AT gamzegokozdogu atrialfunctioninpatientswithbreastcanceraftertreatmentwithanthracyclines |
_version_ |
1716773304656723968 |